Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses, temperature changes,...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Diabetic Foot Ulcer01:31

Diabetic Foot Ulcer

Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proprioceptive synaptic dysfunction is a key feature in mice and humans with spinal muscular atrophy.

Brain : a journal of neurology·2025
Same author

Biallelic Loss-of-Function Variants in <i>BICD1</i> Are Associated with Peripheral Neuropathy and Hearing Loss.

International journal of molecular sciences·2023
Same author

Lack of effect on ambulation of dalfampridine-ER (4-AP) treatment in adult SMA patients.

Neuromuscular disorders : NMD·2020
Same author

Neuromuscular disorders in pregnancy.

Handbook of clinical neurology·2020
Same author

Peripheral neuropathy symptoms in wild type transthyretin amyloidosis.

Journal of the peripheral nervous system : JPNS·2020
Same author

Update on Chemotherapy-Induced Peripheral Neuropathy.

Current neurology and neuroscience reports·2017
Same journal

The Noradrenergic Brain in Parkinson's Disease.

Current neurology and neuroscience reports·2026
Same journal

Mapping the Silent Onset of Parkinson's Disease: Monoamine Imaging in the Era of the Race for Preclinical Intervention.

Current neurology and neuroscience reports·2026
Same journal

Functional and Structural Brain Imaging Correlates of Treatment Response in Functional Movement Disorder.

Current neurology and neuroscience reports·2026
Same journal

Astrocytopathy in Wernicke Encephalopathy and Neuromyelitis Optica Spectrum Disorder. Pathogenic Differences With Occasional Clinical and Neuroimaging Overlap. A Review.

Current neurology and neuroscience reports·2026
Same journal

When is the Radiologically Isolated Syndrome already Multiple Sclerosis According to the 2024 McDonald Criteria?

Current neurology and neuroscience reports·2026
Same journal

Assessment and Management of Post-traumatic Headache.

Current neurology and neuroscience reports·2026
See all related articles

Related Experiment Video

Updated: Jun 27, 2026

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
07:09

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice

Published on: July 16, 2014

Update on medication-induced peripheral neuropathy.

Louis H Weimer1, Noor Sachdev

  • 1The Neurological Institute, 710 West 168th Street, New York, NY 10032, USA. lhw1@columbia.edu

Current Neurology and Neuroscience Reports
|December 17, 2008
PubMed
Summary
This summary is machine-generated.

Medications and toxins can cause peripheral neuropathy, a common condition. This review highlights neurotoxic drugs and environmental exposures, offering insights into preventable causes of nerve damage.

Related Experiment Videos

Last Updated: Jun 27, 2026

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
07:09

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice

Published on: July 16, 2014

Area of Science:

  • Neurology
  • Toxicology
  • Pharmacology

Background:

  • Idiopathic polyneuropathy remains prevalent despite advances in etiological identification.
  • Medication-induced and toxic neuropathies represent a significant, potentially reversible cause of nerve damage.

Purpose of the Study:

  • To review recent advancements in understanding drug- and toxin-induced peripheral neuropathies.
  • To highlight emerging and established neurotoxic agents and their clinical implications.

Main Methods:

  • Literature review of neurotoxic effects of specific medications and environmental toxins.
  • Analysis of recent studies on drug-induced neuropathy, including anticancer and anti-inflammatory agents.
  • Discussion of emerging toxic exposures and their association with neuropathy.

Main Results:

  • Several new drugs, including bortezomib, ixabepilone, oxaliplatin, infliximab, etanercept, leflunomide, and linezolid, are associated with neurotoxicity.
  • The role of statins in neuropathy remains debated, with some evidence suggesting neuroprotection.
  • Dichloroacetate shows promise but is limited by neurotoxicity; a progressive neuropathy in swine workers linked to toxin exposure is described.

Conclusions:

  • Awareness of drug- and toxin-induced neuropathies is crucial for prevention and management.
  • Continued research is needed to elucidate mechanisms and identify safer therapeutic alternatives.
  • Environmental and occupational exposures represent an underrecognized cause of immune-mediated neuropathy.